Group 1 - The stock price of Hualan Biological Engineering reached a historical high, increasing by 4.85% to 42.57 yuan, with a trading volume of 2.7837 million shares and a transaction value of 115 million yuan, resulting in a turnover rate of 1.77% [2] - The latest total market capitalization of Hualan Biological is 6.99 billion yuan, with a circulating market capitalization of 6.681 billion yuan [2] - The pharmaceutical and biotechnology industry, to which Hualan belongs, has an overall increase of 0.48%, with 377 stocks rising, including notable gainers such as Sunflower, Ganli Pharmaceutical, and Xinlitai, which rose by 15.13%, 8.97%, and 6.83% respectively [2] Group 2 - The latest margin trading data shows that Hualan's margin balance is 490 million yuan, with a financing balance of 490 million yuan, which has increased by 42.599 million yuan over the past 10 days, reflecting a growth of 9.52% [2] - According to the company's semi-annual report, Hualan achieved an operating income of 309 million yuan in the first half of the year, representing a year-on-year growth of 8.82%, and a net profit of 43.7321 million yuan, which is an increase of 18.27% year-on-year, with basic earnings per share of 0.2700 yuan and a weighted average return on equity of 1.93% [2]
华兰股份涨4.85%，股价创历史新高